Latest Breaking News On - Brett lauring - Page 1 : vimarsana.com

Kallyope, Inc., a clinical stage biotechnology company discovering and developing novel, oral small-molecule therapeutics for diseases with high unmet need, today announced the initiation of their Phase 2 trial evaluating K-757 and K-833, new oral.

United statesNancy thornberryJay galeotaBrett lauringTrilliant health analysisCenters for diseaseAmerican society for metabolicNational diabetes statisticsProduct serviceKallyope incEnters phaseFirst in class oral approachBoth obesityChief medical officerAmerican societyBariatric surgery